Back to Search
Start Over
Panel confirms positive data for Erbitux in Phase III
- Source :
- BioWorld Week. June 13, 2005, Vol. 13 Issue 24, p4, 1 p.
- Publication Year :
- 2005
-
Abstract
- ImClone System Inc.'s stock jumped more than 14 percent on confirmation from independent reviewers that Erbitux, the company's once scandal-ridden colorectal cancer drug, worked in a Phase III study as [...]
- Subjects :
- ImClone Systems Inc. -- Securities
ImClone Systems Inc. -- Product development
Diagnostic reagents industry -- Securities
Diagnostic reagents industry -- Product development
Colorectal cancer -- Drug therapy
Antimitotic agents -- Product development
Antineoplastic agents -- Product development
Company securities
Biotechnology industry
Erbitux (Medication) -- Product development
Subjects
Details
- Language :
- English
- ISSN :
- 19327765
- Volume :
- 13
- Issue :
- 24
- Database :
- Gale General OneFile
- Journal :
- BioWorld Week
- Publication Type :
- News
- Accession number :
- edsgcl.133246301